US Bancorp
ELOS

US Bancorp’s Syneron Medical Ltd ELOS Stock Holding History

US Bancorp’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-54
Closed -$1K – 3694
2017
Q1 		$1K Buy
+54
New +$522 ﹤0.01% 3525

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

US Bancorp's ELOS Position: Q2 2017 in Review

US Bancorp sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 54 shares — an estimated $1K sold.

US Bancorp first reported a position in ELOS in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • US Bancorp reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • US Bancorp sold 54 Syneron Medical Ltd shares in Q2 2017, an estimated $1K.
  • US Bancorp first reported a position in Syneron Medical Ltd in Q1 2017 and held it in 1 quarter.
  • US Bancorp's Syneron Medical Ltd position peaked at $1K in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.